Patents by Inventor Igor Arturovic Petropavlov

Igor Arturovic Petropavlov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8298523
    Abstract: The present invention relates to pharmaceutical, dermatological, cosmeceutical, or cosmetic compositions comprising (a) interleukin-1 family members consisting of interleukin-1 alpha, interleukin-1 family member 5 (delta), interleukin-1 family member 6 (epsilon), interleukin-1 family member 7 (zeta), interleukin-1 family member 8 (eta), interleukin-1 family member 9, interleukin-1 family member 10 (theta), and interleukin-18; (b) a peptide of the general formula (I): Tyr-X1-X2-Phle-X3-X4-Y, wherein X1 is Gly, L-Ala or D-Ala; X2 is Gly, L-Ala or D-Ala; X3 is absent or independently Leu, Met, Iie, or Val; X4 is absent or independently Ala, Asp, Asn, Glu, Gln, Pro, Arg, Gly, Lys, Thr, or Ser; Y is absent or a sequence of 1 to 5 amino acid residues; and acceptable carriers or diluents.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: October 30, 2012
    Assignee: United Technologies UT AG
    Inventors: Igor Anatolievich Pomytkin, Igor Arturovic Petropavlov
  • Publication number: 20110189126
    Abstract: The present invention relates to pharmaceutical, dermatological, cosmeceutical, or cosmetic compositions comprising (a) interleukin-1 family members consisting of interleukin-1 alpha, interleukin-1 family member 5 (delta), interleukin-1 family member 6 (epsilon), interleukin-1 family member 7 (zeta), interleukin-1 family member 8 (eta), interleukin-1 family member 9, interleukin-1 family member 10 (theta), and interleukin-18; (b) a peptide of the general formula (I): Tyr-X1-X2-Phle-X3-X4-Y, wherein X1 is Gly, L-Ala or D-Ala; X2 is Gly, L-Ala or D-Ala; X3 is absent or independently Leu, Met, lie, or Val; X4 is absent or independently Ala, Asp, Asn, Glu, Gln, Pro, Arg, Gly, Lys, Thr, or Ser; Y is absent or a sequence of 1 to 5 amino acid residues; and acceptable carriers or diluents.
    Type: Application
    Filed: November 7, 2008
    Publication date: August 4, 2011
    Inventors: Igor Anatolievich Pomytkin, Igor Arturovic Petropavlov